News and Media

Latest News Release

Transaction creates increased clinical and economic value for 11,500 specialty providers, including more than 7,000 physicians across 1,200 independent physician practices Transaction creates...


Press Releases

Cardinal Health Announces Quarterly Dividend and Preliminary Shareholder Voting Results at 2017 Annual Meeting

DUBLIN, Ohio, Nov. 8, 2017 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced that the board of directors approved a regular quarterly dividend of $0.4624 per share, payable Jan. 15, 2018, to shareholders of record on Jan. 2, 2018. 

In addition, the company released preliminary results of shareholder voting at its annual meeting of shareholders. Based on preliminary voting results, shareholders re-elected all 11 members to the board of directors, ratified Ernst & Young as the company's independent, registered public accounting firm, and, on an advisory basis, approved the compensation of the company's named executive officers and selected an annual vote on the frequency of future advisory votes to approve executive compensation. One shareholder proposal failed to pass. 

On Monday, Nov. 6, Cardinal Health announced that it named Mike Kaufmann, its current chief financial officer, to serve as the company's next chief executive officer and join the board of directors, effective Jan. 1, 2018. Kaufmann will succeed George Barrett, Cardinal Health's chairman and chief executive officer since 2009, who will continue to serve as executive chairman of the board of directors through the annual meeting of shareholders in November 2018. At that time, Gregory Kenny, Cardinal Health's lead independent director, will assume the role of non-executive chairman.

Results of the shareholder meeting will be posted on the company's Investor Relations page at in the coming days.

About Cardinal Health
Cardinal Health, Inc. is a global, integrated healthcare services and products company, providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices worldwide. The company provides clinically proven medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency from hospital to home. Cardinal Health connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination and better patient management. Because Cardinal Health helps ensure pharmacists and the consumers they serve have access to medications they need while working to help prevent prescription drug diversion, the company and its education partners created Generation Rx, a national program to help prevent the misuse of prescription medications. Backed by nearly 100 years of experience, with approximately 50,000 employees in nearly 60 countries, Cardinal Health ranks #15 on the Fortune 500. For more information, visit, follow @CardinalHealth on Twitter and connect on LinkedIn at company/cardinal-health.

SOURCE Cardinal Health

For further information: Media: Ellen Barry, (614) 553-3858,, Investors: Lisa Capodici, (614) 757-5035,,
More Company News

Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved an increase to its quarterly dividend, to $0.5056 per share, out of the Company's capital surplus. The dividend...


Revenue increased 9% to $54.9 billion GAAP1 operating earnings were $367 million; GAAP diluted EPS was $1.05 Non-GAAP operating earnings increased 10% to $666 million; non-GAAP diluted EPS...


Cardinal Health (NYSE: CAH) announced today that its pharmaceutical distribution contracts with OptumRx, which expire at the end of June 2024, will not be renewed. The company reaffirmed its...


The Consumer Health Logistics Center will be located in Central Ohio and serve as a centralized hub for distribution of consumer health products COLUMBUS, Ohio, April 2, 2024 /PRNewswire/ --...

View all company news »